Cigarette Smoke-Induced Oxidative Stress and Autophagy in Human Alveolar Epithelial Cell Line (A549 Cells)
Overview
General Medicine
Affiliations
Chronic exposure to cigarette smoke (CS) causes structural and functional changes in the respiratory tract. It is a major risk factor for cardiovascular and systemic pulmonary diseases. The aim of this study was to investigate the effect of acute CS exposure (2 h) on oxidative stress, heat shock protein 70 (HSP70) expression, autophagy (LC3 expression), and oxidative stress (DCF fluorescence) in human alveolar epithelial cell line A549. Cell culture medium was conditioned with CS using commercial cigarettes, and A549 cells were grown in modified media for 2 h. In some experiments, A549 cells were pretreated with 100 μM of L-buthionine-sulfoximine (BSO) for 24 h to induce glutathione (GSH) depletion. In the cells grown in CS-conditioned medium, GSH was depleted by more than 30%, and reactive oxygen species were increased. Moreover, there was a considerable overexpression of HSP70 and a substantial accumulation of LC3. Similar changes were found when the cells were pretreated with BSO. We conclude that the short-term exposure of epithelial cells to CS increases oxidative stress that entails enhanced autophagy activity.
Liu Z, Zeng Y, Li R, Yan Y, Yi S, Zhang K J Thorac Dis. 2024; 16(9):6052-6063.
PMID: 39444855 PMC: 11494543. DOI: 10.21037/jtd-23-1836.
Cigarette Smoke-Induced Reactive Oxygen Species Formation: A Concise Review.
Seo Y, Park J, Kim J, Lee M Antioxidants (Basel). 2023; 12(9).
PMID: 37760035 PMC: 10525535. DOI: 10.3390/antiox12091732.
Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers.
Cha S, Jang J, Park S, Ryu S, Cho S, Yang S Antioxidants (Basel). 2023; 12(6).
PMID: 37371940 PMC: 10295620. DOI: 10.3390/antiox12061210.
Costa-Beber L, Costa Rodrigues Guma F Inflamm Res. 2022; 71(12):1433-1448.
PMID: 36264363 DOI: 10.1007/s00011-022-01647-2.
A Barrier to Defend - Models of Pulmonary Barrier to Study Acute Inflammatory Diseases.
Herminghaus A, Kozlov A, Szabo A, Hantos Z, Gylstorff S, Kuebart A Front Immunol. 2022; 13:895100.
PMID: 35874776 PMC: 9300899. DOI: 10.3389/fimmu.2022.895100.